Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sumita Ray | F | 50 | 3 years | |
| Bihua Chen | F | 55 | 4 years | |
| Eric Aguiar | M | 62 | 4 years | |
| Franco Valle | M | 43 | 3 years | |
| Michael Hitchcock | M | 74 | 3 years | |
| Heow Tan | M | 65 | 4 years | |
| Thorsten Kirschberg | M | 54 | 4 years | |
| Terrie Phan | F | - | 3 years | |
| Alex Cacovean | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John C. Doyle | M | 55 | 10 years | |
| Carl F. Grove | M | - |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | - |
| David Domzalski | M | 58 | - | |
| Christopher T. Walsh | M | 80 | - | |
| Mutya Harsch | F | 50 | - | |
| Ronald A. Krasnow | M | 61 | - | |
| Andrew Saik | M | 54 | - | |
| Theodore O. Ebel | M | 54 | 6 years | |
| Ilan Hadar | M | 55 | - | |
| Zeryn Sarpangal | F | 44 | 10 years | |
| Jon B. Bruss | M | - | - | |
| Albert Cha | M | 51 | 4 years | |
| David McGirr | M | 69 | 3 years | |
| Aaron Royston | M | 40 | 2 years | |
| Paul Berns | M | 57 | 3 years | |
| John Fry | M | - |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | 7 years |
| Scott Whitcup | M | 64 | 5 years | |
| H. Culp | M | 60 |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | - |
| Elisabeth Sandoval | F | 62 | - | |
| Crispin Davis | M | 75 |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | - |
| Deryck Charles Maughan | M | 76 |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | - |
| John Kwon | M | 50 | - | |
| Robert Wilson | M | 81 |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | - |
| Christopher Gent | M | 75 |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | - |
| Antonios Bertsos | M | 49 |
Pricewaterhousecoopers LLC
| 6 years |
| Amin Maredia | M | 51 |
Pricewaterhousecoopers LLC
| - |
| Aaron Hawthorne | M | - |
Pricewaterhousecoopers LLC
| 5 years |
| Andrew Munson Fisher | M | - |
Pricewaterhousecoopers LLC
| 3 years |
| Kevin Kuby | M | 55 |
Pricewaterhousecoopers LLC
| 6 years |
| Wesley Smyth | M | - |
Pricewaterhousecoopers LLC
| 6 years |
| George Akopov | M | - |
Pricewaterhousecoopers LLC
| 4 years |
| David T. Searls | M | - |
Pricewaterhousecoopers LLC
| 2 years |
| Teresa Cabreros | F | - |
Pricewaterhousecoopers LLC
| 3 years |
| Jason Wells | M | 45 |
Pricewaterhousecoopers LLC
| 7 years |
| Mark Anthony Rioboli | M | - |
Pricewaterhousecoopers LLC
| 7 years |
| Carolyn Bentley | F | - |
Pricewaterhousecoopers LLC
| 5 years |
| Britta Böckmann | M | - |
Pricewaterhousecoopers LLC
| - |
| Jay Godla | M | - |
Pricewaterhousecoopers LLC
| 4 years |
| Terrance F. Spidell | M | 55 |
Pricewaterhousecoopers LLC
| 15 years |
| Gary J. Brauchle | M | 50 |
Pricewaterhousecoopers LLC
| 6 years |
| Vladimir Karlov | M | - |
Pricewaterhousecoopers LLC
| 1 years |
| Scott Wulinsky | M | 49 |
Pricewaterhousecoopers LLC
| 5 years |
| David T. Calabria | M | 49 |
Pricewaterhousecoopers LLC
| 2 years |
| Edward Anthony Jones | M | 54 |
Pricewaterhousecoopers LLC
| 5 years |
| Reginald Odibosar Nosegbe | M | - |
Pricewaterhousecoopers LLC
| 9 years |
| Marvin SooHoo | M | - |
Pricewaterhousecoopers LLC
| 9 years |
| Jennifer L. Odinet | F | 46 |
Pricewaterhousecoopers LLC
| 10 years |
| Heather Dixon | F | 51 |
Pricewaterhousecoopers LLC
| 11 years |
| Satish Malhotra | M | 49 |
Pricewaterhousecoopers LLC
| - |
| Kee-Hong Kim | M | - | 2 years | |
| Griffiths Jillian | M | - |
Pricewaterhousecoopers LLC
| 19 years |
| Michael John Clancy | M | - |
Pricewaterhousecoopers LLC
| 13 years |
| Jennifer Naylor | F | - |
Pricewaterhousecoopers LLC
| 8 years |
| Dan A. Wolnik | M | - |
Pricewaterhousecoopers LLC
| - |
| Bradford Terence Cook | M | - |
Pricewaterhousecoopers LLC
| 4 years |
| Ashim Mehra | M | - |
Pricewaterhousecoopers LLC
| 2 years |
| Kenneth S. Bring | M | - |
Pricewaterhousecoopers LLC
| 6 years |
| Patricia M. Ranney | F | - |
Pricewaterhousecoopers LLC
| 3 years |
| Matt Chesler | M | - |
Pricewaterhousecoopers LLC
| 3 years |
| Glen Silvestri | M | - |
Pricewaterhousecoopers LLC
| 3 years |
| Wetteny Joseph | M | 52 |
Pricewaterhousecoopers LLC
| 6 years |
| Merry Sheils | F | - |
Pricewaterhousecoopers LLC
| - |
| Marci Ryvicker | F | - |
Pricewaterhousecoopers LLC
| 5 years |
| Mary Margiotta | F | - |
Pricewaterhousecoopers LLC
| 6 years |
| Ronald C. Griffith | M | 76 |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | - |
| Don Charlton | M | - |
Pricewaterhousecoopers LLC
| 7 years |
| Karen Reidy | F | 57 |
Pricewaterhousecoopers LLC
| - |
| Derek Dewan | M | 69 |
Pricewaterhousecoopers LLC
| 17 years |
| Todd Foley | M | 54 |
Pricewaterhousecoopers LLC
| 10 years |
| Laurie Dotter | F | 63 |
Pricewaterhousecoopers LLC
| 4 years |
| Christopher Allen Stratton | M | 55 |
Pricewaterhousecoopers LLC
| 7 years |
| Philip Lee | M | - |
Pricewaterhousecoopers LLC
| 3 years |
| Alan Calderon | M | - |
Pricewaterhousecoopers LLC
| 1 years |
| Timothy Monnin | M | - |
Pricewaterhousecoopers LLC
| 2 years |
| Carol Brosgart | M | 72 |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | - |
| Marc Sobel | M | - |
Pricewaterhousecoopers LLC
| 5 years |
| Kris Corbett | M | 46 |
Pricewaterhousecoopers LLC
| 23 years |
| Jeffrey Addis | M | - |
Pricewaterhousecoopers LLC
| - |
| Jane Russell | F | - |
Pricewaterhousecoopers LLC
| 1 years |
| Rossana Azzara | F | - |
Pricewaterhousecoopers LLC
| - |
| Perry H. Barth | M | - |
Pricewaterhousecoopers LLC
| 6 years |
| Chetan Reddy | M | - |
Pricewaterhousecoopers LLC
| - |
| Tyler Partridge | M | - |
Pricewaterhousecoopers LLC
| 4 years |
| Michael P. Locker | M | - |
Pricewaterhousecoopers LLC
| 2 years |
| Stephanie Elbaum | F | - |
Pricewaterhousecoopers LLC
| 2 years |
| Jack C. Ru | M | - |
Pricewaterhousecoopers LLC
| 1 years |
| Steven Gambuzza | M | - |
Pricewaterhousecoopers LLC
| 2 years |
| Marcus Bracklo | M | 58 |
Pricewaterhousecoopers LLC
| 11 years |
| Andrew M. Brown | M | - |
Pricewaterhousecoopers LLC
| - |
| Leanne Hannon | F | - |
Pricewaterhousecoopers LLC
| 4 years |
| Rohini Sadarangani | F | - |
Pricewaterhousecoopers LLC
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sunny Lee Ryan
- Personal Network
